Midazolam nasal 5MG 2S
Ended Awarded
- Contract number
- SPE2DX26FPFVE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,735
Award facts
- Contract value 100% obligated
- $3,735.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $3,735.00 to DMS Pharmaceutical Group Inc. for the supply of Midazolam Nasal 5mg. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order carries a firm fixed-price structure with an ultimate completion date of October 31, 2025, and will be performed at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceuticals including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This delivery order represents one of numerous awards issued to DMS Pharmaceutical Group under the PPV-G GEN V program, positioning the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DX26FPFVE?
SPE2DX26FPFVE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 31, 2025.
How much is contract SPE2DX26FPFVE worth?
The government has obligated $3,735 on SPE2DX26FPFVE.
Is contract SPE2DX26FPFVE an order under another contract?
Yes. SPE2DX26FPFVE is a delivery order under SPE2DX15D9762, an indefinite delivery contract.
Was contract SPE2DX26FPFVE competed?
The extent of competition for SPE2DX26FPFVE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award